Efficacy of melatonin for sleep disturbance following traumatic brain injury

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This randomized controlled trial will evaluate the effectiveness of melatonin, a naturally occurring hormone, in alleviating sleep disturbances in people with traumatic brain injury. If successful, melatonin therapy could substantially improve the quality of life of individuals with TBI, improving their participation in vocational, leisure and social activities and enhancing their emotional well-being.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $225,119.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

drug efficacy | intervention study | melatonin | randomised controlled trial (RCT) | rehabilitation | sleep disturbance | traumatic brain injury (TBI)